(2021) highlighted that probiotic therapy can increase glucose metabolism, reduce peripheral and central inflammatory responses (e.g., reduction of interleukin-6 (IL-6), hs-CRP, and tumor necrosis factor -α (TNF-α) in PD patients, and increase motor and non-motor function. This evidence concerns the gene IL6 and Parkinson disease.